Literature DB >> 22331541

[Routine outcome monitoring in forensic psychiatry: a long story cut short].

K Goethals1, H J C van Marle.   

Abstract

BACKGROUND: It is difficult to do research relating to forensic psychiatric patients because there are a number of methodological problems inherent in systematic measurements in forensic psychiatry. AIM: To give readers an overview of the rom literature and some information about worthwhile developments in the field.
METHOD: We studied the Dutch and international literature and took a closer look at some recent developments.
RESULTS: For several reasons it is almost impossible to set up randomised controlled trials in forensic psychiatry. The main problems are as follows: the selection criteria for forensic psychiatric treatment are not psychiatric or they lack a behavioural focus, there is no standardised forensic psychiatric treatment for patients with a variety of psychiatric disorders and no theory concerning the relationship between disorder and offence. rom, therefore, may help to measure the clinical effectiveness of the treatments investigated. The forensic psychiatric literature gives very little advice on the choice of appropriate instruments. Clearly, however, the instruments have to embrace three distinct domains: psychopathology, the quality of life and the risk of recidivism.
CONCLUSION: At least, however, we can recommend that all forensic psychiatric institutions should work together to develop a ROM system.

Entities:  

Mesh:

Year:  2012        PMID: 22331541

Source DB:  PubMed          Journal:  Tijdschr Psychiatr        ISSN: 0303-7339


  2 in total

Review 1.  Forensic Assertive Community Treatment: A Review of the Literature.

Authors:  Thomas Marquant; Bernard Sabbe; Meike Van Nuffel; Kris Goethals
Journal:  Community Ment Health J       Date:  2016-07-15

2.  Routine Outcome Monitoring and Clinical Decision-Making in Forensic Psychiatry Based on the Instrument for Forensic Treatment Evaluation.

Authors:  Frida C A van der Veeken; Jacques Lucieer; Stefan Bogaerts
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.